Analyst Price Targets — CVS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 5, 2026 3:24 pm | Michael Cherny | Leerink Partners | $98.00 | $79.49 | StreetInsider | Leerink Partners Reiterates Outperform Rating on CVS Health (CVS), partnership with Google Cloud "positive AI development" |
| January 28, 2026 1:09 pm | — | Argus Research | $90.00 | $73.21 | TheFly | CVS Health price target lowered to $90 from $91 at Argus |
| January 6, 2026 1:49 pm | — | Bernstein | $91.00 | $80.57 | TheFly | CVS Health price target raised to $91 from $87 at Bernstein |
| December 12, 2025 11:40 am | — | Bernstein | $87.00 | $80.84 | TheFly | CVS Health price target raised to $87 from $86 at Bernstein |
| December 10, 2025 1:11 pm | Ann Hynes | Mizuho Securities | $95.00 | $79.05 | TheFly | CVS Health price target raised to $95 from $88 at Mizuho |
| December 10, 2025 12:15 pm | — | Robert W. Baird | $92.00 | $78.24 | TheFly | CVS Health price target raised to $92 from $82 at Baird |
| December 10, 2025 11:47 am | Jessica Tassan | Piper Sandler | $101.00 | $78.24 | TheFly | CVS Health price target raised to $101 from $99 at Piper Sandler |
| December 10, 2025 11:46 am | — | Morgan Stanley | $93.00 | $78.24 | TheFly | CVS Health price target raised to $93 from $89 at Morgan Stanley |
| December 10, 2025 11:25 am | — | Barclays | $93.00 | $78.24 | TheFly | CVS Health price target raised to $93 from $87 at Barclays |
| December 10, 2025 10:43 am | Kevin Caliendo | UBS | $97.00 | $78.24 | TheFly | CVS Health price target raised to $97 from $96 at UBS |
Latest News for CVS
Focus Partners Advisor Solutions LLC increased its holdings in shares of CVS Health Corporation (NYSE: CVS) by 82.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 19,316 shares of the pharmacy operator's stock after acquiring an additional 8,703 shares during
CVS Health and Google have partnered to use artificial intelligence and related cloud-based technology to increase consumer and patient engagement, and "ultimately support better health outcomes,” the companies said Thursday.
CVS Health will launch an AI-enabled platform in partnership with Alphabet's Google Cloud unit that will bring together data from diverse sources to help customers manage their health in real time, they said on Thursday.
Health100, a health technology services subsidiary of CVS Health will launch a new first-of-its-kind AI-native consumer engagement platform to be the destination of choice for a connected, proactive, and personalized health care experience powered by Google Cloud's AI technologies WOONSOCKET, R.I. and SUNNYVALE, Calif.
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.